Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-19

Clinical Trial Update: Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial assessing the safety and efficacy of Gratisovir (sofosbuvir) with ribavirin in pediatric patients. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gratisovir (sofosbuvir)
  • Ribavirin (ribavirin)

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Pharmacological Action | Phase 2, Phase 3 | Status: UNKNOWN